Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4507)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2022 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang QQ, Zhou YC, Zhou Ge YJ, Qin G, Yin TF, Zhao DY, Tan C, Yao SK. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer. World J Clin Cases 2022; 10(22): 7686-7697 [PMID: 36158487 DOI: 10.12998/wjcc.v10.i22.7686] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i22/7686.htm |
| Number | Citing Articles |
| 1 |
R. Sachin Sriram, P. Anitha, K. Balachander, P. Chandra, A. Paramasivam, J. Vijayashree Priyadharsini. Genetic alterations in CDKN2A interacting network and their putative association with head and neck squamous cell carcinoma. Human Gene 2024; 40: 201276 doi: 10.1016/j.humgen.2024.201276
|
| 2 |
Mahima Mishra, Rubai Ahmed, Deepak Kumar Das, Devlina Das Pramanik, Sandeep Kumar Dash, Arindam Pramanik. Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers. ACS Biomaterials Science & Engineering 2024; 10(8): 4740 doi: 10.1021/acsbiomaterials.4c00606
|
| 3 |
Han Chen, Jiao Deng, Tie-Wei Hou, Yong-Qi Shan. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis. Journal of Ethnopharmacology 2024; 325: 117907 doi: 10.1016/j.jep.2024.117907
|
| 4 |
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Alexandru Laurentiu Chiotoroiu, Camelia Diaconu. Colorectal Cancer: From Risk Factors to Oncogenesis. Medicina 2023; 59(9): 1646 doi: 10.3390/medicina59091646
|
| 5 |
Di Zhang, Tao Wang, Yi Zhou, Xipeng Zhang. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors. Medicine 2023; 102(14): e33468 doi: 10.1097/MD.0000000000033468
|
| 6 |
Gang Wang, Fei Li, Zhi Min Zhu, Kun Wang, Xiao‐Na Xu, Feng‐Qian Li. Identification and verification of KEAP1‐related genes and targets regulated by potential ingredients in KRAS mutant colorectal cancer. Precision Medical Sciences 2024; 13(3): 148 doi: 10.1002/prm2.12142
|
| 7 |
Meng Zhang, Xiuli Zheng, Chunyan Wang, Shengmian Li. Data‐independent acquisition combined with liquid chromatography mass spectrometry technique to detect prognostic protein markers in type I gastric neuroendocrine neoplasm. Rapid Communications in Mass Spectrometry 2024; 38(16) doi: 10.1002/rcm.9849
|
| 8 |
Khalid Saad Alharbi. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research. Pathology - Research and Practice 2024; 254: 155138 doi: 10.1016/j.prp.2024.155138
|
| 9 |
Ahmed Salem, Sanaa Ahmed, Maha Khalfallah, Nema Hamadan, Walaa ElShikh, Mohamed Alfaki. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma . Cureus 2024; doi: 10.7759/cureus.60586
|